Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2025
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-13419
Lindsay Corporation
(Exact name of registrant as specified in its charter)
Delaware
47-0554096
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
18135 Burke Street, Suite 100, Omaha, Nebraska
68022
(Address of principal executive offices)
(Zip Code)
402‑829-6800
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1.00 par value
LNN
New York Stock Exchange, Inc.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer
☒
Accelerated filer
☐
Non‑accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of January 5, 2026, 10,454,669 shares of the registrant’s common stock were outstanding.
INDEX FORM 10-Q
Page
Part I – FINANCIAL INFORMATION
3
ITEM 1 – Financial Statements
Condensed Consolidated Statements of Earnings for the three months ended November 30, 2025 and November 30, 2024
Condensed Consolidated Statements of Comprehensive Income for the three months ended November 30, 2025 and November 30, 2024
4
Condensed Consolidated Balance Sheets as of November 30, 2025, November 30, 2024, and August 31, 2025
5
Condensed Consolidated Statements of Shareholders’ Equity for the three months ended November 30, 2025 and November 30, 2024
6
Condensed Consolidated Statements of Cash Flows for the three months ended November 30, 2025 and November 30, 2024
7
Notes to the Condensed Consolidated Financial Statements
8
ITEM 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
16
ITEM 3 – Quantitative and Qualitative Disclosures about Market Risk
22
ITEM 4 – Controls and Procedures
Part II – OTHER INFORMATION
23
ITEM 1 – Legal Proceedings
ITEM 1A – Risk Factors
ITEM 2 – Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 3 – Defaults Upon Senior Securities
ITEM 4 – Mine Safety Disclosures
ITEM 5 – Other Information
ITEM 6 – Exhibits
24
SIGNATURES
25
- 2 -
ITEM 1 - Financial Statements
LINDSAY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited)
Three months ended
($ and shares in thousands, except per share amounts)
November 30,2025
November 30,2024
Operating revenues
$
155,818
166,281
Cost of operating revenues
105,716
116,315
Gross profit
50,102
49,966
Operating expenses:
Selling expense
11,019
10,211
General and administrative expense
14,838
15,008
Engineering and research expense
4,640
3,864
Total operating expenses
30,497
29,083
Operating income
19,605
20,883
Other income:
Interest income, net
3,319
493
Other (expense) income, net
(1,038
)
658
Total other income
2,281
1,151
Earnings before income taxes
21,886
22,034
Income tax expense
5,362
4,870
Net earnings
16,524
17,164
Earnings per share:
Basic
1.55
1.58
Diluted
1.54
1.57
Shares used in computing earnings per share:
10,673
10,853
10,699
10,903
Cash dividends declared per share
0.37
0.36
See accompanying notes to condensed consolidated financial statements.
- 3 -
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
($ in thousands)
Other comprehensive income (loss):
Defined benefit pension plan adjustment, net of tax
37
Foreign currency translation adjustment, net of hedging activities and tax
2,686
(6,359
Total other comprehensive income (loss), net of tax expense of $390 and $608, respectively
2,711
(6,322
Total comprehensive income
19,235
10,842
- 4 -
CONDENSED CONSOLIDATED BALANCE SHEETS
($ and shares in thousands, except par values)
August 31,2025
ASSETS
Current assets:
Cash and cash equivalents
199,622
194,066
250,575
Receivables, net of allowance of $5,529, $5,046, and $6,089, respectively
129,014
120,875
113,027
Inventories, net
146,388
158,255
136,859
Other current assets
31,974
28,948
32,303
Total current assets
506,998
502,144
532,764
Property, plant, and equipment:
Cost
330,455
286,670
315,060
Less accumulated depreciation
(175,317
(168,688
(172,753
Property, plant, and equipment, net
155,138
117,982
142,307
Intangibles, net
23,353
24,591
23,331
Goodwill
84,421
83,941
84,459
Operating lease right-of-use assets
17,566
15,009
18,096
Deferred income tax assets
18,573
12,375
19,525
Equity method investment
8,107
—
8,763
Other noncurrent assets
14,244
14,959
11,591
Total assets
828,400
771,001
840,836
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
57,248
53,185
48,670
Current portion of long-term debt
186
229
233
Other current liabilities
90,991
76,435
94,689
Total current liabilities
148,425
129,849
143,592
Pension benefits liabilities
3,350
4,101
3,418
Long-term debt
114,792
114,948
114,810
Operating lease liabilities
16,722
14,824
17,354
Deferred income tax liabilities
1,816
646
1,024
Other noncurrent liabilities
25,133
18,174
27,788
Total liabilities
310,238
282,542
307,986
Shareholders' equity:
Preferred stock of $1 par value - authorized 2,000 shares; no shares issued and outstanding
Common stock of $1 par value - authorized 25,000 shares; 19,188, 19,145, and 19,167 shares issued, respectively
19,188
19,145
19,167
Capital in excess of stated value
113,268
104,995
113,042
Retained earnings
758,003
700,345
745,397
Less treasury stock - at cost, 8,595, 8,277, and 8,363 shares, respectively
(341,476
(299,703
(311,224
Accumulated other comprehensive loss, net
(30,821
(36,323
(33,532
Total shareholders' equity
518,162
488,459
532,850
Total liabilities and shareholders' equity
- 5 -
Lindsay Corporation and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
Shares ofcommonstock
Shares oftreasurystock
Commonstock
Capital inexcess ofstatedvalue
Retainedearnings
Treasurystock
Accumulatedothercomprehensiveloss,net
Totalshareholders’equity
Balance at August 31, 2024
19,124
8,277
104,369
687,093
(299,692
(30,001
480,893
Comprehensive income:
Other comprehensive loss
Cash dividends ($0.36) per share
(3,912
Repurchase of common stock
(11
Issuance of common shares under share compensation plans, net
21
(1,351
(1,330
Share-based compensation expense
1,977
Balance at November 30, 2024
Balance at August 31, 2025
8,363
Other comprehensive income
Cash dividends ($0.37) per share
(3,918
232
(30,252
(1,144
(1,123
1,370
Balance at November 30, 2025
8,595
- 6 -
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
November 30, 2025
November 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization
5,312
5,412
Provision for uncollectible accounts receivable
(252
62
Deferred income taxes
1,477
1,589
Unrealized foreign currency transaction gain
(248
(511
Other, net
413
(217
Changes in assets and liabilities:
Receivables
(15,123
(6,442
Inventories
(8,993
(5,968
303
1,251
5,251
16,656
(7,522
(9,978
Other noncurrent assets and liabilities
891
608
Net cash (used in) provided by operating activities
(597
21,603
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment
(14,476
(9,142
Proceeds from settlement of net investment hedge
835
Payments for settlement of net investment hedge
(98
Other investing activities, net
(1,152
(401
Net cash used in investing activities
(15,628
(8,806
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid
Common stock withheld for payroll tax obligations
(1,253
(1,450
Repurchase of common shares
Other financing activities, net
51
52
Net cash used in financing activities
(35,372
(5,310
Effect of exchange rate changes on cash and cash equivalents
644
(4,300
Net change in cash and cash equivalents
(50,953
3,187
Cash and cash equivalents, beginning of period
190,879
Cash and cash equivalents, end of period
- 7 -
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 – Basis of Presentation
The condensed consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and do not include all of the disclosures normally required by U.S. generally accepted accounting principles (“U.S. GAAP”) as contained in Lindsay Corporation’s (the “Company”) Annual Report on Form 10-K. Accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s most recent Annual Report on Form 10-K for the fiscal year ended August 31, 2025.
In the opinion of management, the condensed consolidated financial statements of the Company reflect all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position and the results of operations and cash flows for the periods presented. The results for interim periods are not necessarily indicative of trends or results expected by the Company for a full year. The condensed consolidated financial statements were prepared using U.S. GAAP. These principles require us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results could differ from these estimates.
Recent Accounting Guidance Not Yet Adopted
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires entities to disclose more detailed information in their reconciliation of their statutory tax rate to their effective tax rate. The Company will adopt this ASU as part of its fiscal 2026 Annual Report on Form 10-K and does not expect any impact on its results of operations, as the changes primarily relate to enhanced disclosures.
In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (DISE), which requires additional disclosure of the nature of expenses included in the income statement in response to longstanding requests from investors for more information about an entity’s expenses. The Company will adopt this ASU as part of its fiscal 2028 Annual Report on Form 10-K and does not expect any impact on its results of operations, as the changes primarily relate to enhanced disclosures.
Note 2 – Revenue Recognition
Disaggregation of Revenue
A breakout by segment of revenue recognized over time versus at a point in time for the three months ended November 30, 2025 and 2024 is as follows:
Irrigation
Infrastructure
Total
Point in time
124,816
15,940
140,756
Over time
8,621
1,301
9,922
Revenue from contracts with customers
133,437
17,241
150,678
Lease revenue
5,140
Total operating revenues
22,381
139,368
12,102
151,470
7,719
1,358
9,077
147,087
13,460
160,547
5,734
19,194
Further disaggregation of revenue is disclosed in Note 13 – Business Segments.
- 8 -
For contracts with an initial length longer than 12 months, the unsatisfied performance obligations were $78.8 million at November 30, 2025, almost all of which is expected to be satisfied within the next 12 to 18 months.
Contract Balances
Contract assets arise when recorded revenue for a contract exceeds the amounts billed under the terms of such contract. Contract liabilities arise when billed amounts exceed revenue recorded. Amounts are billable to customers upon various measures of performance, including achievement of certain milestones and completion of specified units of completion of the contract. At November 30, 2025, November 30, 2024, and August 31, 2025, contract assets amounted to $2.0 million, $3.1 million, and $1.1 million, respectively. These amounts are included within other current assets on the condensed consolidated balance sheets.
Contract liabilities include advance payments from customers and billings in excess of delivery of performance obligations. At November 30, 2025, November 30, 2024, and August 31, 2025, contract liabilities amounted to $16.0 million, $18.6 million, and $14.2 million, respectively. Contract liabilities are included within other current liabilities and other noncurrent liabilities on the condensed consolidated balance sheets. During the Company’s three months ended November 30, 2025 and 2024, the Company recognized $4.8 million and $9.6 million of revenue that were included in the liabilities as of August 31, 2025 and 2024, respectively. The revenue recognized was due to applying advance payments received for the performance obligations completed during the quarter.
Note 3 – Net Earnings per Share
Basic earnings per share is calculated on the basis of weighted average outstanding common shares. Diluted earnings per share is calculated on the basis of basic weighted average outstanding common shares adjusted for the dilutive effect of stock options, restricted stock unit awards and other dilutive securities.
The following table shows the computation of basic and diluted net earnings per share for the three months ended November 30, 2025 and 2024:
Numerator:
Denominator:
Weighted average shares outstanding
Diluted effect of stock awards
26
50
Weighted average shares outstanding assuming dilution
Basic net earnings per share
Diluted net earnings per share
Certain stock options and restricted stock units were excluded from the computation of diluted net earnings per share because their effect would have been anti-dilutive. Performance stock units are excluded from the calculation of dilutive potential common shares until the threshold performance conditions have been satisfied. The number of securities excluded from the computation of earnings per share because their effect would have been anti-dilutive was not significant for the three months ended November 30, 2025 and 2024.
Note 4 – Income Taxes
The Company recorded income tax expense of $5.4 million and $4.9 million for the three months ended November 30, 2025 and 2024, respectively.
It is the Company’s policy to report income tax expense for interim periods using an estimated annual effective income tax rate. The estimated annual effective income tax rate was 22.4 percent and 22.0 percent for the three months ended November 30, 2025 and 2024, respectively. The increase in the estimated annual effective income tax rate relates primarily to the change in earnings mix among foreign operations.
- 9 -
The tax effects of significant or unusual items are not considered in the estimated annual effective income tax rate. The tax effects of such discrete events are recognized in the interim period in which the events occur. The impact of discrete items amounted to additional expense of $0.5 million for the three months ended November 30, 2025 and was not significant for the three months ended November 30, 2024.
Note 5 – Inventories
Inventories consisted of the following as of November 30, 2025, November 30, 2024, and August 31, 2025:
Raw materials and supplies
68,850
87,861
70,510
Work in process
9,786
12,369
7,186
Finished goods and purchased parts, net
89,382
79,365
78,631
Total inventory value before LIFO adjustment
168,018
179,595
156,327
Less adjustment to LIFO value
(21,630
(21,340
(19,468
Of the $146.4 million, $158.3 million, and $136.9 million of net inventories at November 30, 2025, November 30, 2024, and August 31, 2025, respectively, $36.9 million, $40.8 million, and $35.0 million, respectively, was valued on the last-in, first-out ("LIFO") basis, and $109.5 million, $117.5 million, and $101.9 million, respectively, was valued on the first-in, first-out ("FIFO") or average cost methods.
Note 6 – Long-Term Debt
The following table sets forth the outstanding principal balances of the Company’s long-term debt as of the dates shown:
Series A Senior Notes
115,000
Elecsys Series 2006A Bonds
434
263
Total debt
115,186
115,434
115,263
Less current portion
(186
(229
(233
Less unamortized debt issuance costs
(208
(257
(220
Total long-term debt
Principal payments on the debt are due as follows:
Due within
$ in thousands
1 year
Thereafter
- 10 -
Note 7 – Fair Value Measurements
The following table presents the Company’s financial assets and liabilities measured at fair value, based upon the level within the fair value hierarchy in which the fair value measurements fall, as of November 30, 2025, November 30, 2024, and August 31, 2025. There were no transfers between any levels for the periods presented.
Level 1
Level 2
Level 3
Derivative liabilities
(12,994
Derivative assets
1,897
(156
August 31, 2025
(14,622
The Company enters into derivative instrument agreements to manage risk in connection with changes in foreign currency. The Company only enters into derivative instrument agreements with counterparties who have highly rated credit and does not enter into derivative instrument agreements for trading or speculative purposes. The fair values are based on inputs other than quoted prices that are observable for the asset or liability and are determined by standard calculations and models that use readily observable market parameters. These inputs include foreign currency exchange rates and interest rates. Industry standard data providers are the primary source for forward and spot rate information for both interest rates and foreign currency exchange rates.
The Company has entered into various cross currency swaps that mature between the third quarter of fiscal 2026 and the first quarter of fiscal 2028 with a total notional amount of $175.0 million, or €163.2 million. The Company elected the spot method for designating these swaps as net investment hedges. Changes in the fair value of these contracts are reported in accumulated other comprehensive loss, net on the condensed consolidated balance sheets and the fair value of these contracts is recorded within other current liabilities and other noncurrent liabilities on the condensed consolidated balance sheets. The fair value of these contracts as of November 30, 2025, is included in the table above as derivative liabilities. During the three months ended November 30, 2025 and 2024, the Company recognized translation gains of $1.2 million and $1.9 million, respectively, within other comprehensive income related to its net investment hedges.
At November 30, 2025, the Company had an outstanding foreign currency forward contract to sell a notional amount of 95.5 million South African rand at fixed prices to settle during the next fiscal quarter. This foreign currency forward contract does not qualify as a hedge of a net investment in foreign operations.
There were no required fair value adjustments for assets and liabilities measured at fair value on a non-recurring basis for the three months ended November 30, 2025 or 2024.
Note 8 – Commitments and Contingencies
In the ordinary course of its business operations, the Company enters into arrangements that obligate it to make future payments under contracts such as lease agreements. Additionally, the Company is involved, from time to time, in commercial litigation, employment disputes, administrative proceedings, business disputes and other legal proceedings. The Company has established accruals for certain proceedings based on an assessment of probability of loss. The Company believes that any such currently-pending proceedings are either covered by insurance or would not have a material effect on the business or its condensed consolidated financial statements if decided in a manner that is unfavorable to the Company. Such proceedings are exclusive of environmental remediation matters which are discussed separately below.
Infrastructure Products Litigation
The Company is currently defending a number of product liability lawsuits arising out of vehicle collisions with highway barriers incorporating the Company’s X-Lite® end terminal. Despite the September 2018 reversal of a sizable judgment against a
- 11 -
competitor and the October 2023 dismissal of the FCA Lawsuit (as defined below), the Company expects that the significant attention brought to the infrastructure products industry by the original judgment may lead to additional lawsuits being filed against the Company and others in the industry.
Following the March 2019 filing of a qui tam lawsuit (as amended, the “FCA Lawsuit”) by an individual relator (the “Relator”) on behalf of the United States and 12 individual states, in the United States District Court for the Northern District of New York (the “U.S. District Court”), the Department of Justice, Civil Division and the U.S. Attorney's Office for the Northern District of New York (the “U.S. Attorney’s Office”) proceeded to initiate an investigation into the Relator’s allegations relating to the Company's X-Lite end terminal and potential violations of the False Claims Act. On September 28, 2023, the U.S. Attorney’s Office submitted a letter motion (the “Letter Motion”) informing the U.S. District Court that the United States had investigated the Relator’s allegations and now sought to move to dismiss the FCA Lawsuit as it had “determined that dismissal is commensurate with the public interest because the claims lack merit and the matter does not warrant the continued expenditure of resources to pursue or monitor the action.” The U.S. Attorney’s Office also noted that it had “been advised by counsel for the 12 states that the states [had] no objection to the U.S. District Court declining to exercise supplemental jurisdiction over the remaining state claims and to dismissing those claims without prejudice to the states.” On October 2, 2023, the U.S. District Court granted the Letter Motion and indicated that a motion to dismiss could be filed without further order or pre-motion conference. On October 12, 2023, after the Relator proceeded to file his own notice of voluntary dismissal, the U.S. Attorney’s Office filed its notice of consent to the Relator’s voluntary dismissal. On October 26, 2023, the U.S. District Court ordered the dismissal of the FCA Lawsuit without prejudice as to the Relator, the United States, and each of the 12 state plaintiffs.
On November 27, 2023, following the dismissal of the Relator’s FCA Lawsuit, the Relator filed under seal subsequent qui tam lawsuits on behalf of each of the States of Tennessee and California against the Company, certain of its subsidiaries, and certain third parties which originally designed the X-Lite end terminal. The Tennessee lawsuit (the “Tennessee FATA Lawsuit”) was filed in the Circuit Court of Davidson County, Nashville, Tennessee (the “Tennessee Circuit Court”), and the California lawsuit (the “California FATA Lawsuit”) was filed in the Superior Court of California, Sacramento County (the “California Superior Court”). Both lawsuits make substantially similar allegations as those originally made in the FCA Lawsuit with respect to the Company’s X-Lite end terminal and potential violations of each state’s respective Fraud Against Taxpayers Act. The State of Tennessee filed under seal a notice of its election to decline to intervene on March 26, 2024, the Tennessee Circuit Court ordered the Tennessee FATA Lawsuit unsealed later in 2024, and the Company learned of the Tennessee FATA Lawsuit when it and its named subsidiaries were served in June 2024. The State of California similarly filed under seal a notice of its election to decline to intervene on September 13, 2024, the California Superior Court ordered the California FATA Lawsuit unsealed in 2025, and the Company learned of the California FATA Lawsuit when it and its named subsidiaries were served in June 2025.
The Company, certain of its subsidiaries, and certain third parties which originally designed the X-Lite end terminal have also been named in a lawsuit filed on June 9, 2020 in the Circuit Court of Cole County, Missouri by Missouri Highways and Transportation Commission (“MHTC”). MHTC alleges, among other things, that the X-Lite end terminal was defectively designed and failed to perform as designed, intended, and advertised, leading to MHTC’s removal and replacement of X-Lite end terminals from Missouri’s roadways. MHTC alleges strict liability (defective design and failure to warn), negligence, breach of express warranties, breach of implied warranties (merchantability and fitness for a particular purpose), fraud, and public nuisance. MHTC seeks compensatory damages, interest, attorneys’ fees, and punitive damages.
The Company believes it has meritorious factual and legal defenses to each of the lawsuits discussed above and is prepared to vigorously defend its interests. Based on the information currently available to the Company, the Company does not believe that a loss is probable in any of these lawsuits; therefore, no accrual has been included in the Company’s consolidated financial statements. While it is reasonably possible that a loss may be incurred, the Company is unable to estimate a range of potential loss due to the complexity and current status of these lawsuits. However, the Company maintains insurance coverage to mitigate the impact of adverse exposures in these lawsuits and does not expect that these lawsuits will have a material adverse effect on its business or its consolidated financial statements.
Environmental Remediation
In previous years, the Company committed to a plan to remediate environmental contamination of the groundwater at and adjacent to its Lindsay, Nebraska facility (the “site”). The current estimated aggregate accrued cost of $10.6 million is based on consideration of remediation options which the Company believes could be successful in meeting the long-term regulatory requirements of the site. The Company submitted a revised remedial alternatives evaluation report to the U.S. Environmental Protection Agency (“EPA”) and the Nebraska Department of Environment and Energy (the “NDEE”) in August 2020 to review remediation alternatives and proposed plans for the site. While the proposed remediation plan is preliminary and has not been approved by the EPA or the NDEE, they approved an in situ thermal remediation pilot study that was conducted by the Company at a specific location on the site. The Company completed the pilot program in the fourth quarter of fiscal 2023. A final report
- 12 -
was submitted to the EPA and NDEE for review in November 2023. The Company continues to work with the EPA and the NDEE on finalizing the proposed remediation plans for the site. Of the total liability as of November 30, 2025, $8.0 million was calculated on a discounted basis using a discount rate of 1.2 percent, which represents a risk-free rate. This discounted portion of the liability amounts to $9.1 million on an undiscounted basis at November 30, 2025.
The Company accrues the anticipated cost of investigation and remediation when the obligation is probable and can be reasonably estimated. While the plan has not been formally approved by the EPA, the Company believes the current accrual is a good faith estimate of the long-term cost of remediation at this site; however, the estimate of costs and their timing could change as a result of a number of factors, including but not limited to (1) EPA input on the proposed remediation plan and any changes which the EPA may subsequently require, (2) refinement of cost estimates and length of time required to complete remediation and post-remediation operations and maintenance, (3) effectiveness of the technology chosen in remediation of the site as well as changes in technology that may be available in the future, and (4) unforeseen circumstances existing at the site. As a result of these factors, the actual amount of costs incurred by the Company in connection with the remediation of contamination of its Lindsay, Nebraska site could exceed the amounts accrued for this expense at this time. While any revisions could be material to the operating results of any fiscal quarter or fiscal year, the Company does not expect such additional expenses would have a material adverse effect on its liquidity or financial condition.
The following table summarizes the environmental remediation liability classifications included in the condensed consolidated balance sheets as of November 30, 2025, November 30, 2024, and August 31, 2025:
509
10,123
Total environmental remediation liabilities
10,632
Note 9 – Warranties
The following table provides the changes in the Company’s product warranties:
Product warranty accrual balance, beginning of period
$14,158
$14,180
Liabilities accrued for warranties during the period
1,092
1,278
Warranty claims paid during the period
(1,637)
(1,997)
Product warranty accrual balance, end of period
$13,613
$13,461
Note 10 – Share-Based Compensation
The Company’s current share-based compensation plans, approved by the stockholders of the Company, provides for awards of stock options, restricted shares, restricted stock units (“RSUs”), stock appreciation rights, performance shares, and performance stock units (“PSUs”) to employees and non-employee directors of the Company. The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors based on estimated fair values. Share-based compensation expense was $1.5 million and $1.9 million for the three months ended November 30, 2025 and 2024, respectively.
The following table illustrates the type and fair value of share-based compensation awards granted during the three months ended November 30, 2025 and 2024:
Number ofunitsgranted
Weighted averagegrant-date fair valueper award
Stock options
51,883
35.07
43,011
42.19
RSUs
32,557
110.21
31,525
117.11
PSUs
30,045
109.85
28,280
133.30
- 13 -
The RSUs granted during the three months ended November 30, 2025 and 2024 included 2,868 and 3,516 units, respectively, that will be settled in cash. The weighted average stock price on the date of grant was $114.35 and $121.16 per award for the three months ended November 30, 2025 and 2024, respectively. Share issuances are presented net of shares withheld to cover payroll taxes of $1.3 million and $1.5 million for the three months ended November 30, 2025 and 2024, respectively.
The following table provides the assumptions used in determining the fair value of the stock options awarded during the three months ended November 30, 2025 and 2024:
Three months ended November 30,
2025
2024
Dividend yield
1.3
%
1.2
Volatility
32.7
36.8
Risk-free interest rate
3.6
4.1
Expected life (years)
The PSUs granted during fiscal 2026 include performance goals based on a return on invested capital ("ROIC") and total shareholder return ("TSR") relative to the Company's peers during the performance period. The awards actually earned will range from zero to two hundred percent of the targeted number of PSUs and will be paid in shares of common stock. Shares earned will be distributed upon vesting on the first day of November following the end of the three-year performance period. For the ROIC portion of the award, the Company is accruing compensation expense based on the estimated number of shares expected to be issued utilizing the most current information available to the Company at the date of the condensed consolidated financial statements. For the TSR portion of the award, compensation expense is recorded ratably over the three-year term of the award based on the estimated grant date fair value.
The fair value of the TSR portion of the awards granted during the three months ended November 30, 2025 and 2024 was estimated at the grant date using a Monte Carlo simulation model which included the following assumptions:
33.2
35.2
3.5
Expected term (years)
Note 11 – Other Current Liabilities
Other current liabilities:
Compensation and benefits
19,713
18,006
28,799
Warranties
13,613
13,461
14,158
Contract liabilities
12,192
16,660
13,474
Tax related liabilities
11,277
5,454
7,617
Dealer related liabilities
8,986
8,131
9,919
4,174
3,589
4,113
Deferred revenue - lease
3,035
1,045
4,465
Accrued insurance
1,003
997
975
Accrued environmental liabilities
Other
16,489
8,583
10,660
Total other current liabilities
Note 12 – Share Repurchases
The Company’s Board of Directors previously authorized a share repurchase program of up to $250.0 million of common stock with no expiration date. Under the program, shares may be repurchased in privately negotiated and/or open market transactions as well as under formalized trading plans in accordance with the guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The Company’s share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act.
- 14 -
During the three months ended November 30, 2025, the Company repurchased 232 thousand shares of its common stock under the program in open market transactions for $30.3 million, including excise taxes of $0.2 million. During the three months ended November 30, 2024, the amount of common stock repurchased by the Company under the program in open market transactions was not significant. The repurchases completed in the first quarter of fiscal 2026 fully depleted the previous share repurchase authorization.
In November 2025, the Company's Board of Directors authorized a new share repurchase program of up to $150.0 million of the Company's outstanding common stock. As of November 30, 2025, the amount available under this repurchase program remained at $150.0 million.
Note 13 – Business Segments
The Company’s chief operating decision maker (“CODM”) is the Chief Executive Officer. The CODM utilizes operating income to guide resource allocation across reportable segments as part of the Company’s strategic and annual planning efforts, and to assess segment performance by comparing planned results to actual outcomes. The CODM manages the Company's business activities in two reportable segments: Irrigation and Infrastructure.
Irrigation – This reporting segment includes the manufacture and marketing of center pivot, lateral move, and hose reel irrigation systems and large diameter steel tubing, as well as various innovative technology solutions such as GPS positioning and guidance, variable rate irrigation, remote irrigation management and scheduling technology, and industrial internet of things, or "IIoT", solutions. The irrigation reporting segment consists of one operating segment.
Infrastructure – This reporting segment includes the manufacture and marketing of moveable barriers, specialty barriers, crash cushions and end terminals, and road marking and road safety equipment. The infrastructure reporting segment consists of one operating segment.
The Company had no single customer who represented 10 percent or more of its total revenues during the three months ended November 30, 2025 or 2024.
Three months ended November 30, 2025
Consolidated
(1)
92,813
12,903
40,624
9,478
Operating expenses
17,670
4,984
22,654
Segment operating income
22,954
4,494
27,448
Unallocated corporate expenses
7,843
(1) includes North America revenues of $74,312 and international revenues of $59,125
Three months ended November 30, 2024
105,195
11,120
41,892
8,074
17,156
3,950
21,106
24,736
4,124
28,860
7,977
(1) includes North America revenues of $77,669 and international revenues of $69,418
- 15 -
ITEM 2 ‑ Management's Discussion and Analysis of Financial Condition and Results of Operations
Concerning Forward‑Looking Statements
This Quarterly Report on Form 10-Q contains not only historical information, but also forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical are forward-looking and reflect information concerning possible or assumed future results of operations and planned financing of the Company. In addition, forward-looking statements may be made orally or in press releases, conferences, reports, on the Company's web site, or otherwise, in the future by or on behalf of the Company. When used by or on behalf of the Company, the words “expect,” “anticipate,” “estimate,” “believe,” “intend,” “will,” “plan,” “predict,” “project,” “outlook,” “could,” “may,” “should” or similar expressions generally identify forward-looking statements. The entire section entitled “Executive Overview and Outlook” should be considered forward-looking statements. For these statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve a number of risks and uncertainties, including but not limited to those discussed in the “Risk Factors” section in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2025. Readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results or conditions, which may not occur as anticipated. Actual results or conditions could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein and in the Company’s other public filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the Company’s fiscal year ended August 31, 2025, as well as other risks and uncertainties not now anticipated. The risks and uncertainties described herein and in the Company’s other public filings are not exclusive and further information concerning the Company and its businesses, including factors that potentially could materially affect the Company's financial results, may emerge from time to time. Except as required by law, the Company assumes no obligation to update forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.
Accounting Policies
In preparing the Company’s condensed consolidated financial statements in conformity with U.S. GAAP, management must make a variety of decisions which impact the reported amounts and the related disclosures. These decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. In making these decisions, management applies its judgment based on its understanding and analysis of the relevant circumstances and the Company’s historical experience.
The Company’s accounting policies that are most important to the presentation of its results of operations and financial condition, and which require the greatest use of judgments and estimates by management, are designated as its critical accounting policies. See discussion of the Company’s critical accounting policies under Item 7 in the Company’s Annual Report on Form 10-K for the Company’s fiscal year ended August 31, 2025. Management periodically re-evaluates and adjusts its critical accounting policies as circumstances change. There were no significant changes in the Company’s critical accounting policies during the three months ended November 30, 2025.
Recent Accounting Guidance
See Note 1 – Basis of Presentation and the disclosure therein of recently adopted accounting guidance to the condensed consolidated financial statements set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Executive Overview and Outlook
Operating revenues for the three months ended November 30, 2025 were $155.8 million, a decrease of 6 percent compared to $166.3 million for the three months ended November 30, 2024. Irrigation segment revenues decreased 9 percent to $133.4 million and infrastructure segment revenues increased 17 percent to $22.4 million. Net earnings for the three months ended November 30, 2025 were $16.5 million, or $1.54 per diluted share, compared to net earnings of $17.2 million, or $1.57 per diluted share, for the three months ended November 30, 2024. Operating income was lower than the prior year primarily due to lower revenues. This decrease in earnings was partially offset by higher other income compared to the prior year, while the effective income tax rate was slightly higher than the prior year.
- 16 -
The primary drivers for the Company’s irrigation segment are the need for irrigated agricultural crop production, which is tied to population growth and the attendant need for expanded food production, and the need to use water resources efficiently. These drivers are affected by a number of factors, including the following:
- 17 -
The USDA's forecasted increase in estimated 2025 net farm income is not expected to have a meaningful positive impact on demand for irrigation equipment as the increase results primarily from government support payments while income from crop receipts is expected to be slightly lower compared to the prior year. Favorable weather conditions in key U.S. markets during the growing season have resulted in higher crop production and increased inventories of crops in 2025 and has maintained downward pressure on commodity prices in the near term.
The most significant opportunities for growth in irrigation sales over the next several years continue to be in international markets where irrigation use is less developed and demand is driven not only by commodity prices and net farm income, but also by food security, water scarcity and population growth. While international irrigation markets remain active with opportunities for further development and expansion, regional political and economic factors, including armed conflict, currency conditions and other factors can create a challenging environment. Additionally, international results are influenced by large project sales which tend to fluctuate and can be difficult to forecast accurately. In the fourth quarter of fiscal 2024, the Company began shipment under a multi-year supply agreement to provide irrigation systems and remote management and scheduling technology for a large project in the Middle East and North Africa (MENA) region. The project was valued at over $100 million in revenue, with equipment deliveries occurring throughout fiscal 2025 and completing in the first quarter of fiscal 2026. Additionally, in December 2025, the Company announced a new supply agreement to provide irrigation systems and remote management and scheduling technology for a new large project in the MENA region. The project, valued at more than $80 million in revenue, is expected to be recognized over the period beginning in the second quarter of fiscal 2026 with approximately $70 million of the total contract revenue anticipated to be recognized in the current fiscal year.
The infrastructure business continues to be driven by the Company's transportation safety products, the demand for which largely depends on government spending for road construction and improvements. The enactment of the Infrastructure Investment and Jobs Act ("IIJA") in November 2021 introduced $110 billion in incremental federal funding for roads, bridges, and other transportation projects, which the Company anticipates may support higher demand for its transportation safety products as states utilize these funds in construction projects. The federal programs under IIJA run through September 2026.
The backlog of unshipped orders at November 30, 2025 was $119.2 million compared with $168.2 million at November 30, 2024. Included in these backlogs are amounts of $8.5 million and $17.4 million, respectively, for orders that are not expected to be fulfilled within the subsequent 12 months. The backlog in both segments was lower compared to the prior year, with the decrease resulting primarily attributed to from deliveries related to the large irrigation project in the MENA region that was included in the backlog as of November 30, 2024. The Company’s backlog can fluctuate from period to period due to the seasonality, cyclicality, timing and execution of contracts. Backlog typically represents long-term projects as well as short lead-time orders, and therefore is generally not a good indication of the next fiscal quarter’s revenues.
- 18 -
Results of Operations
For the Three Months ended November 30, 2025 compared to the Three Months ended November 30, 2024
The following section presents an analysis of the Company’s operating results displayed in the condensed consolidated statements of earnings for the three months ended November 30, 2025 and 2024. It should be read together with the industry segment information in Note 13 to the condensed consolidated financial statements:
Percent Change
(6%)
0%
Gross margin
32.2
30.0
Operating expenses (1)
5%
Operating margin
12.6
98%
10%
Effective income tax rate
24.5
22.1
(4%)
Irrigation Segment
(9%)
(3%)
30.4
28.5
3%
(7%)
17.2
16.8
Infrastructure Segment
17%
42.3
42.1
26%
9%
20.1
21.5
Revenues
Operating revenues for the three months ended November 30, 2025 decreased 6 percent to $155.8 million from $166.3 million for the three months ended November 30, 2024, as irrigation revenues decreased $13.7 million and infrastructure revenues increased $3.2 million. The irrigation segment provided 86 percent of the Company’s revenue during the three months ended November 30, 2025 as compared to 88 percent for the three months ended November 30, 2024.
North America irrigation revenues for the three months ended November 30, 2025 of $74.3 million decreased $3.4 million, or 4 percent, from $77.7 million for the three months ended November 30, 2024. The decrease resulted primarily from lower unit sales volume and was partially offset by slightly higher average selling prices compared to the prior year. Unfavorable market conditions continue to weigh on farmer sentiment and temper demand for irrigation equipment in North America.
International irrigation revenues for the three months ended November 30, 2025 of $59.1 million decreased $10.3 million, or 15 percent, from $69.4 million for the three months ended November 30, 2024. The decrease resulted primarily from lower sales in Brazil and Western Europe, along with lower project revenues in the MENA region. Elevated interest rates and credit constraints continue to be headwinds to capital investment by farmers in Brazil. The current year includes a favorable impact of foreign currency translation of $1.5 million compared to the prior year.
- 19 -
Infrastructure segment revenues for the three months ended November 30, 2025 of $22.4 million increased $3.2 million, or 17 percent, from $19.2 million for the three months ended November 30, 2024. The increase was primarily attributable to higher sales of road safety products while Road Zipper System revenues were similar compared to the prior year.
Gross Profit
Gross profit for the three months ended November 30, 2025 of $50.1 million was comparable to $50.0 million for the three months ended November 30, 2024. Gross margin was 32.2 percent of sales for the three months ended November 30, 2025 compared with 30.0 percent of sales for the three months ended November 30, 2024. Higher irrigation gross margin resulted from a lower proportion of international irrigation project revenue in the current year that was dilutive to gross margin, while infrastructure gross margin was comparable to the prior year.
Operating Expenses
Operating expenses of $30.5 million for the three months ended November 30, 2025 increased $1.4 million, or 5 percent, compared with $29.1 million for the three months ended November 30, 2024. Higher selling and engineering and research expenses were partially offset by lower administrative expenses.
Other Income, net
The Company recorded other income of $2.3 million for the three months ended November 30, 2025 compared to other income of $1.2 million for the three months ended November 30, 2024. The increase resulted primarily from higher net interest income, partially offset by foreign currency transaction losses, compared to the prior year.
Income Taxes
The Company recorded income tax expense of $5.4 million and $4.9 million for the three months ended November 30, 2025 and 2024, respectively. The effective income tax rate was 24.5 percent and 22.1 percent for the three months ended November 30, 2025 and 2024, respectively. The estimated annual effective tax rate in the current year is comparable to the prior year, but the current year includes an unfavorable discrete impact of share-based compensation vesting of approximately $0.5 million. The impact of discrete items in the prior year was not significant.
Liquidity and Capital Resources
The Company's cash and cash equivalents totaled $199.6 million at November 30, 2025 compared with $250.6 million at August 31, 2025, and $194.1 million at November 30, 2024. The decrease during the three months ended November 30, 2025 resulted primarily from repurchases of common stock, increases in working capital, and capital expenditures. The Company requires cash for financing its receivables and inventories, paying operating expenses and capital expenditures, and for dividends and share repurchases. The Company meets its liquidity needs and finances its capital expenditures from its available cash and funds provided by operations along with borrowings under its credit arrangements described below. In the normal course of business, the Company enters into contracts and commitments which obligate the Company to make future payments. The Company does not have any additional off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. The Company believes its current cash resources, projected operating cash flow, and remaining capacity under its continuing bank lines of credit are sufficient to cover all its expected working capital needs, planned capital expenditures and dividends. The Company may require additional borrowings to fund potential acquisitions in the future.
The Company’s total cash and cash equivalents held by foreign subsidiaries were approximately $105.8 million, $94.1 million, and $97.4 million as of November 30, 2025, November 30, 2024, and August 31, 2025, respectively. The Company does not consider its earnings in foreign subsidiaries to be permanently reinvested and accrues applicable taxes on the earnings of its foreign subsidiaries. The Company does not expect the repatriation of these funds, and any applicable taxes, to have a significant impact on the Company’s overall liquidity.
Net working capital was $358.6 million at November 30, 2025, as compared with $372.3 million at November 30, 2024 and $389.2 million at August 31, 2025. Cash used in operating activities totaled $0.6 million during the three months ended November 30, 2025, compared to cash provided by operating activities of $21.6 million during the three months ended November 30, 2024. The increase in working capital and decrease in cash generated from operating activities was driven primarily by increases in receivables and inventories.
- 20 -
Cash flows used in investing activities totaled $15.6 million during the three months ended November 30, 2025 compared to $8.8 million during the three months ended November 30, 2024. Purchases of property, plant, and equipment were $14.5 million in the current year, compared to $9.1 million in the prior year.
Cash flows used in financing activities totaled $35.4 million during the three months ended November 30, 2025 compared to cash flows used in financing activities of $5.3 million during the three months ended November 30, 2024. The current year included $30.3 million of share repurchases, while the amount of share repurchases in the prior year was not significant.
Capital Allocation Plan
The Company’s capital allocation plan is to continue investing in revenue and earnings growth, combined with a defined process for enhancing returns to stockholders. Under the Company’s capital allocation plan, the priorities for uses of cash include:
Capital Expenditures
Capital expenditures for fiscal 2026 are expected to range from $50 million to $55 million, including equipment replacement, productivity improvements, new product development, and commercial growth investments. The increase over recent levels of capital expenditures is primarily related to modernization and productivity improvements planned at certain manufacturing facilities. The Company’s management does maintain flexibility to modify the amount and timing of some of the planned expenditures in response to economic conditions.
Dividends
In the first quarter of fiscal 2026, the Company paid a quarterly cash dividend to stockholders of $0.37 per common share, or $3.9 million, compared to a quarterly cash dividend of $0.36 per common share, or $3.9 million, in the first quarter of fiscal 2025.
Share Repurchases
The Company’s Board of Directors previously authorized a share repurchase program of up to $250.0 million of common stock with no expiration date. Under the program, shares could be repurchased in privately negotiated and/or open market transactions as well as under formalized trading plans in accordance with the guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. During the three months ended November 30, 2025, the Company repurchased $30.3 million of its common shares compared to an insignificant amount of repurchases in the prior year. The repurchases completed in the first quarter of fiscal 2026 fully depleted the previous $250.0 million share repurchase authorization.
Long-Term Borrowing Facilities
Senior Notes. The Company has outstanding $115.0 million in aggregate principal amount of Senior Notes, Series A (the “Senior Notes”). The entire principal of the Senior Notes is due and payable on February 19, 2030. Interest on the Senior Notes is payable semi-annually at a fixed annual rate of 3.82 percent. Borrowings under the Senior Notes are unsecured. The Company used the proceeds of the sale of the Senior Notes for general corporate purposes, including acquisitions and dividends.
Revolving Credit Facility. The Company has outstanding a $50.0 million unsecured Amended and Restated Revolving Credit Facility (the “Revolving Credit Facility”) with Wells Fargo Bank, National Association (“Wells Fargo”) expiring August 26, 2030. The Company intends to use borrowings under the Revolving Credit Facility for working capital purposes and to fund potential future acquisitions. At November 30, 2025 and 2024, the Company had no outstanding borrowings under the Revolving Credit Facility. The amount of borrowings available at any time under the Revolving Credit Facility is reduced
- 21 -
by the amount of standby letters of credit issued by Wells Fargo then outstanding. At November 30, 2025, the Company had the ability to borrow up to $50.0 million under the Revolving Credit Facility. The Revolving Credit Facility may be increased by up to an additional $50.0 million at any time, subject to additional commitment approval. Borrowings under the Revolving Credit Facility bear interest at a variable rate equal to the Secured Overnight Financing Rate (“SOFR”) plus a margin of between 100 and 210 basis points depending on the Company’s leverage ratio then in effect (which resulted in a variable rate of 5.47 percent at November 30, 2025), subject to adjustment as set forth in the loan documents for the Revolving Credit Facility. Interest is paid on a monthly to quarterly basis depending on loan type. The Company currently pays an annual commitment fee on the unused portion of the Revolving Credit Facility. The fee is between 0.125 percent and 0.2 percent on the unused balance depending on the Company’s leverage ratio then in effect (which resulted in a fee of 0.125 percent at November 30, 2025).
Borrowings under the Revolving Credit Facility have equal priority with borrowings under the Company’s Senior Notes. Each of the credit arrangements described above include certain covenants relating primarily to the Company’s financial condition. These financial covenants include a funded debt to EBITDA leverage ratio and an interest coverage ratio. In the event that the loan documents for the Revolving Credit Facility were to require the Company to comply with any financial covenant that is not already included or is more restrictive than what is already included in the arrangement governing the Senior Notes, then such covenant shall be deemed incorporated by reference for the benefit of holders of the Senior Notes. Upon the occurrence of any event of default of these covenants, including a change in control of the Company, all amounts outstanding thereunder may be declared to be immediately due and payable. At November 30, 2025 and 2024, the Company was in compliance with all financial loan covenants contained in its credit arrangements in place as of each of those dates.
Contractual Obligations and Commercial Commitments
There have been no material changes in the Company’s contractual obligations and commercial commitments as described in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2025.
ITEM 3 – Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes from the Company’s quantitative and qualitative disclosures about market risk previously disclosed in the Company’s most recent Annual Report on Form 10-K. See discussion of the Company’s quantitative and qualitative disclosures about market risk under Part II, Item 7A in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2025.
Disclosure Controls and Procedures
The Company carried out an evaluation under the supervision and the participation of the Company’s management, including the Company’s Chief Executive Officer (CEO) and Chief Financial Officer (CFO), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e). Based upon that evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of November 30, 2025.
Changes in Internal Control over Financial Reporting
The CEO and CFO determined that there has not been any significant change to the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
- 22 -
See the disclosure in Note 8 – Commitments and Contingencies to the condensed consolidated financial statements set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q, which disclosure is hereby incorporated herein by reference.
There have been no material changes from risk factors previously disclosed in the Company’s most recent Annual Report on Form 10-K. See the discussions of the Company’s risk factors under Part I, Item 1A in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2025.
The table below sets forth information with respect to purchases of the Company’s common stock made by or on behalf of the Company during the three months ended November 30, 2025:
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of Shares Purchased
Average Price Paid Per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)($ in thousands)
September 1, 2025 to September 30, 2025
87,910
138.28
17,856
October 1, 2025 to October 31, 2025
143,977
124.14
November 1, 2025 to November 30, 2025
150,000
231,887
129.50
(1) The Company previously announced on January 3, 2014 that its Board of Directors authorized a share repurchase program of up to $250.0 million of common stock through January 2, 2016, and on July 22, 2015, the Company further announced that its Board of Directors increased its outstanding share repurchase authorization by $100.0 million with no expiration date (the “2014 Repurchase Program”). Under the 2014 Repurchase Program, shares may be repurchased in privately negotiated and/or open market transactions as well as under formalized trading plans in accordance with the guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (“Rule 10b5-1”). The repurchases completed in the first quarter of fiscal 2026 fully depleted the 2014 Repurchase Program and caused it to expire on October 31, 2025. On November 5, 2025, the Company announced that its Board of Directors authorized a new share repurchase program for the Company to repurchase up to $150.0 million of the Company's outstanding common stock (the “2025 Repurchase Program”). Under the 2025 Repurchase Program, shares may be repurchased from time to time in open market transactions at prevailing market prices and/or in privately negotiated transactions, as well as under formalized trading plans in accordance with the guidelines specified under Rule 10b5-1. The 2025 Repurchase Program does not have any expiration date.
None.
Not applicable.
- 23 -
Exhibit
No.
Description
3.1
Restated Certificate of Incorporation of the Company, incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on December 14, 2006.
3.2
Amended and Restated By‑Laws of the Company, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on August 22, 2023.
Specimen Form of Common Stock Certificate, incorporated by reference to Exhibit 4(a) of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2006.
10.1
Employment Agreement, dated October 7, 2025, between the Company and Sam Hinrichsen, incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on October 14, 2025.
10.2*
Employment Agreement, dated November 6, 2025, between the Company and Brian J. Magnusson.
10.3*
Separation Agreement and General Release, dated November 11, 2025, between the Company and Gustavo E. Oberto.
10.4*
Lindsay Corporation Policy on Payment of Director Fees and Expenses.
10.5*
Lindsay Corporation Management Incentive Plan (MIP) 2026 Plan Year. **
31.1*
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 18 U.S.C. Section 1350.
31.2*
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 18 U.S.C. Section 1350.
32.1*
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 18 U.S.C. Section 1350.
101*
Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline Extensible Business Reporting Language ("Inline XBRL").
104*
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).
Management contract or compensatory plan or arrangement required to be filed as an exhibit hereto pursuant to Item 6 of Part II of Form 10-Q.
* Filed herein.
** Certain confidential portions of this exhibit were omitted by means of marking such portions with brackets and asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.
- 24 -
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 8th day of January 2026.
LINDSAY CORPORATION
By:
/s/ SAMUEL S. HINRICHSEN
Name:
Samuel S. Hinrichsen
Title:
Senior Vice President and Chief Financial Officer
(on behalf of the registrant and as principal financial officer)
- 25 -